Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

Abstract Background Skin autofluorescence (SAF) is a non-invasive marker of tissue accumulation of advanced glycation endproducts (AGE). Recently, we demonstrated in the general population that elevated SAF levels predict the development of type 2 diabetes (T2D), cardiovascular disease (CVD) and mor...

Full description

Bibliographic Details
Main Authors: Henderikus E. Boersma, Robert P. van Waateringe, Melanie M. van der Klauw, Reindert Graaff, Andrew D. Paterson, Andries J. Smit, Bruce H. R. Wolffenbuttel
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Endocrine Disorders
Subjects:
Ageing
Cardiovascular disease
Diabetes
Mortality
Prediction
Skin autofluorescence
Online Access:https://doi.org/10.1186/s12902-020-00676-4

Internet

https://doi.org/10.1186/s12902-020-00676-4

Similar Items